Get started
CiplaCiplaCipla

Cipla

No trades
See on Supercharts
Overview
Financials News Ideas Discussions Technicals Seasonals

CIPLA chart


Full chart

Key stats


Market capitalization
‪14.58 B‬ USD
Dividend yield (indicated)
—
Price to earnings Ratio (TTM)
27.3
Basic EPS (TTM)
0.7 USD
Net income (FY)
‪497.86 M‬ USD
Revenue (FY)
‪3.11 B‬ USD
Shares float
—
Beta (1Y)
—

About CIPLA LTD


Sector
Health Technology
CEO
Umang Vohra
Headquarters
Mumbai
Website
cipla.com
Founded
1935
FIGI
BBG000Q4YY55
Cipla Ltd. engages in the manufacture and distribution of healthcare products and bulk drugs. It operates through the following segments: Pharmaceuticals and New Ventures. The Pharmaceuticals segment develops, manufactures, sells and distributes generic or branded generic medicines as well as active pharmaceutical ingredients. The New Ventures segment includes the operations of the two wholly owned subsidiaries, Cipla Health Ltd., a consumer healthcare company and Cipla BioTec Pvt. Ltd, which is into the business of Biosimilars. The company was founded by Khwaja Abdul Hamied in 1935 and is headquartered in Mumbai, India.

Financials


Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:—
‪0.00‬

CIPLA news



Ideas



See all ideas 

Technicals

Summarizing what the indicators are suggesting.
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy

Seasonals


Displays a symbol's price movements over previous years to identify recurring trends.